Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.050
+0.010 (0.49%)
At close: Apr 28, 2026, 4:00 PM EDT
2.012
-0.038 (-1.86%)
After-hours: Apr 28, 2026, 5:50 PM EDT
Equillium Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
35
Market Cap
129.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Innate Pharma | 10.57M |
| Alpha Cognition | 10.22M |
| Kazia Therapeutics | 1.27M |
| Cardiff Oncology | 593.00K |
| Connect Biopharma Holdings | 64.00K |
EQ News
- 15 hours ago - Equiniti (EQ) Launches DealTrax™: A Digital-First Platform for Corporate Actions and M&A Events - GlobeNewsWire
- 8 days ago - Equillium to Participate in Oppenheimer's 2026 Innovation on the Island Event - GlobeNewsWire
- 20 days ago - Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists - GlobeNewsWire
- 26 days ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights - GlobeNewsWire
- 5 weeks ago - Equillium to Participate in the 38th Annual Roth Conference - GlobeNewsWire
- 6 weeks ago - Equillium Announces $35 Million Financing with RA Capital Management - GlobeNewsWire
- 2 months ago - Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire